Figure 8.
Tumor levels of VEGF mRNA after systemic administration of PTX and VEGF siRNA co-delivery NPs (N/P = 30, C/N = 1/5; PTX content: 6.04%) in 4T1Luc tumor-bearing mice. *p < 0.05, **p < 0.01 vs. Control (n = 4).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.